Vertex基因编辑疗法在最新财报中反弹
Vertex’s CRISPR therapy rebounds in latest earnings
生命科学资讯
生物技术与制药领域的最新动态
Immunic公司完成私募融资；Vertex囊性纤维化药物在幼童中展现积极数据
Immunic's private placement; Vertex's cystic fibrosis data in young kids
赛默飞世尔与查尔斯河裁员；药明康德与Vertex签订合同
Thermo Fisher, Charles River workforce cuts; WuXi signs contract with Vertex
艾伯维押注PD-1/VEGF双靶点竞赛；Alnylam与Vertex公布业绩预期
AbbVie buys into PD-1/VEGF sweepstakes; Alnylam and Vertex set expectations
Vertex基因编辑疗法在儿童血液疾病治疗中取得早期目标
Vertex CRISPR therapy hits early goal in children with blood disorders